Role of Ayurved medication in Fetal Growth restriction

RANDOMIZED COMPARATIVE CLINICAL STUDY ON THE EFFICACY OF MADHUKADI SADHITA KSHEERA AND MADHUMALINI VASANT RASA IN GARBHASHOSHA (FETAL GROWTH RESTRICTION) - RANDOMIZED COMPARATIVE CLINICAL STUDY ON THE EFFICACY OF MADHUKADI SADHITA KSHEERA AND MADHUMALINI VASANT RASA IN GARBHASHOSHA (FETAL GROWTH RESTRICTION)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036319

Enrollment

Registered

2021-09-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O365- Maternal care for known or suspected poor fetal growth

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women having Garbhashosha diagnosed by clinical sign symptoms and ultrasonography Age group 20 to 35 years Asymmetrical IUGR Gestational age between 28 to 34 weeks of primi or multi parity Upto third Gravida Patient having Hb percentage more than 7 gram percentage

Exclusion criteria

Exclusion criteria: Pregnancy with PIH Symmetrical IUGR Known cases of DAIBETES MELLITIS Gestational DAIBETES MELLITIS Cardiac and Renal Disease Kochs Twin pregnancy Congenital malformations of fetus Patients of Abruption of placenta

Design outcomes

Primary

Measure	Time frame
Improvement in fetal weight Termination of Pregnancy at TermTimepoint: baseline at 4 weeks 8 weeks and after delivery	—

Secondary

Measure	Time frame
ABSENCE OF MATERNAL COMPLICATIONS LIKE PREVENTION OF POSTPARTUM PHYSCOLOGICAL PROBLEMS HIGH APGAR SCORE PREVENTION OF BIRTH ASPHYXIATimepoint: immediately after delivery	—

Countries

India

Contacts

Public ContactDR ASOKAN V

PARUL INSTITUTE OF AYURVED

drasokan24@gmail.com6361740431

Outcome results